Approval · Notice of Compliance 32370 · 2023
PRO-DUTASTERIDE: Notice of Compliance 32370
Issued December 18, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32370
- Date
- December 18, 2023
- Company
- Pro Doc LimiteeLaval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Administrative: Licensing Agreement Between Two Manufacturers
- Canadian reference product
- AVODART (Glaxosmithkline Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PRO-DUTASTERIDE | 02543990 | Marketed |
Medicinal ingredients
- DUTASTERIDE 0.5 MG per CAP